myelodysplastic syndrome
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Clear diagnosis of spleen deficiency type low-risk MDS anemia patients and signed informed consent.
Exclusion criteria
Exclusion criteria: 1. MDS combined with 5q-; 2. Blood transfusion dependence (WHO requires at least every 1 week to lose 1U red blood cells within 4 months); 3. Liver and kidney dysfunction (blood aspartate aminotransferase, alanine aminotransferase, creatinine concentration exceeds normal value more than 3 times online). 4. In addition to the treatment of drugs defined in this topic, other drugs need to be treated. 5. Recently participated in other drug clinical trials (within 2 weeks of Chinese medicine, 7 half-life periods of western medicine) 6. Those who could not complete the prescribed observations after being selected were not coordinated.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| hemoglobin;TCM symptom scores; | — |
Secondary
| Measure | Time frame |
|---|---|
| hepcidin;inflammatory factors;iron metabolism; | — |
Countries
China
Contacts
Shanghai Baoshan Hospital of Integrated Traditional Chinese and Western Medicine (Baoshan Branch of Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine)